SPY337.88+0.44 0.13%
DIA279.77-0.27 -0.10%
IXIC11,104.77+92.53 0.84%

Lumos Pharma shares are trading higher after the company announced the sale of its Priority Review Voucher for $100 million. UPDATE: Shares have since reversed, now lower.

Benzinga · -